
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jose Karam, MD is a board certified urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is an Assistant Professor at Division of Surgery.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2009 - 2011
- University of Texas Southwestern Medical CenterResidency, Urology, 2005 - 2009
- University of Texas Southwestern Medical CenterInternship, Surgery, 2004 - 2005
- American University of Beirut Faculty of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2011 - 2027
- AZ State Medical License 2023 - 2026
- GA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Urology Urology
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsClinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, Zita D Lim, Priya Rao
European Urology Oncology. 2025-04-01 - 1 citationsImmune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective ...Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam
Nature Communications. 2025-02-21 - 4 citationsImmunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.Tejas Jammihal, Renee Maria Saliby, Chris Labaki, Hanna Soulati, Juan Gallegos
Nature Cancer. 2025-02-01
Press Mentions
- KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024